Arikayce 590 mg / 8.4 mL inhalation suspension Images
Generic Name: amikacin liposome
This medication has been identified as Arikayce 590 mg / 8.4 mL inhalation suspension. It is supplied by Insmed Incorporated.
Arikayce is used in the treatment of Mycobacterium avium-intracellulare, Treatment and belongs to the drug class aminoglycosides. Arikayce 590 mg / 8.4 mL inhalation suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Arikayce
- Generic Name
- amikacin liposome
- Strength
- 590 mg / 8.4 mL inhalation suspension
- Availability
- Prescription only
- Drug Class
- Aminoglycosides
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Insmed Incorporated
- National Drug Code (NDC)
- 71558-0590
More about Arikayce (amikacin liposome)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: aminoglycosides
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
